Allena Pharmaceuticals, Inc.
ALNADelisted Sep 14, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001624658
Allena Pharmaceuticals, Inc. was delisted on Sep 14, 2022; its insiders filed their last Form 4 on Feb 2, 2022; 25 institutions reported holding it in 13F filings for Q2 2022, worth $1.71M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Allena Pharmaceuticals, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 2 | 0 | −2 |
| Shares | 252.6K | 0 | −252.6K (−100.0%) |
| Value | $4.00K | $0 | −$4.00K (−100.0%) |
New holders (0)
Institutions that held Allena Pharmaceuticals, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
None.
Sold out (2)
Institutions that held Allena Pharmaceuticals, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Acadian Asset Management LLC | 237,610 | $4.00K |
| 1620 Investment Advisors, Inc. | 15,000 | $0 |